Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

National Institute for Health Research is opened for HTA researcher-led applications in the UK

21 Sep 2020

On September 03, 2020, National Institute for Health Research (NIHR) opened HTA researcher-led proposal submissions. The NIHR HTA Program funds research to evaluate the effectiveness of technologies within the NHS. Grants are available for primary research and evidence synthesis on themes proposed by the researchers.

Proposals should evaluate the clinical effectiveness and cost-effectiveness of health technology. For diagnostic technologies, researchers may suggest equivalent evaluations. Technologies considered are not only new drugs or equipment but also procedures, devices, tests, settings of care, screening programs, and any intervention used in the treatment, prevention, or diagnosis of disease. They should be currently used in the NHS, or likely to be used if supported by the results of the research. The efficacy of the technologies should have already been assessed. 

See more details on the application process for primary research here and for evidence synthesis here. The closing date for submissions is January 6, 2021.

The criteria for the assessment of proposals are the need for the evidence in the NHS and the scientific rigor of the research. If successful, the applications will be considered at an HTA Funding Committee in March 2021, with first stage decisions communicated to applicants in March 2021.

See more information here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.